tumour

  1. T

    Breast Cancer Tumour Growth Inhibited By OMEGA-3s

    A lifelong diet rich in omega-3 fatty acids can inhibit growth of breast cancer tumours by 30 per cent, according to new research from the University of Guelph. The study, published recently in the Journal of Nutritional Biochemistry, is believed to be the first to provide unequivocal evidence...
  2. T

    New Brain Tumour Gene Identified For Meningiomas

    The causes of brain tumours have been hard to discern in most cases. But Umeå researchers have previously identified an inherited predisposition for brain tumours, and now, in an international collaboration, they have also discovered a genetic variation that increases the risk of a certain type...
  3. T

    New Campaign Asks Parents To Be Brain Tumour Aware

    A new campaign is being launched to help parents and health professionals spot the signs of brain tumours in children and young people. HeadSmart aims to speed up diagnosis rates and raise awareness of brain tumour symptoms. Louise Pennell visited the doctor several times with her four year old...
  4. T

    Genetics Of Children's Brain Tumour Unlocked

    Researchers have identified an important cancer gene that could lead to more effective drugs being developed to fight paediatric high grade glioma, a disease which currently has a poor prognosis. The discovery, published today in the Journal of Clinical Oncology, was one of a number of...
  5. T

    Circadian's VGX-100 Significantly Inhibits Tumour Growth In Animal Models Of Human Ca

    Circadian Technologies Limited (ASX.CIR) today released data demonstrating that its lead anti-cancer therapeutic, VGX-100, significantly inhibits tumour growth in a variety of different animal models (tumour xenografts) of human cancer. These data indicate that, if clinically validated, VGX-100...
  6. T

    Circadian's VGX-100 Significantly Inhibits Tumour Growth In Animal Models Of Human Ca

    Circadian Technologies Limited (ASX.CIR) today released data demonstrating that its lead anti-cancer therapeutic, VGX-100, significantly inhibits tumour growth in a variety of different animal models (tumour xenografts) of human cancer. These data indicate that, if clinically validated, VGX-100...
  7. T

    Circadian's VGX-100 Significantly Inhibits Tumour Growth In Animal Models Of Human Ca

    Circadian Technologies Limited (ASX.CIR) today released data demonstrating that its lead anti-cancer therapeutic, VGX-100, significantly inhibits tumour growth in a variety of different animal models (tumour xenografts) of human cancer. These data indicate that, if clinically validated, VGX-100...
  8. T

    Cellular Origins Of Tasmanian Devil Facial Tumour Disease Pinpointed

    An international team of scientists has found that cells that protect nerves are likely to be the origins of a fatal cancer known as Devil Facial Tumour Disease (DFTD) that is spreading rapidly through populations of Tasmanian devils in Australia: if unchecked, scientists estimate the cancer...
Back
Top